Stanford Medicine has secured a five-year, $25 million NIH grant to establish the Stanford University Artificial Intelligence and Technology Collaboratory for Precision Health and Interventions in Aging and AD/ADRD (SU-AITC), focused on tailoring dementia treatments with AI.

The initiative will integrate brain imaging, AI, and everyday-life data—including contactless sensing—to measure symptoms, monitor progression, and adapt care as patient needs evolve.

Leadership comprises Ehsan Adeli, Feng Vankee Lin, and James Landay, who bring expertise in AI in medicine, dementia care, and human-centered design.

Projects will explore precision dementia interventions, potentially involving wearables, cognitive training software, personalized neurotechnologies, at-home sensing, and robotic support for therapy or exercise.

The center will collaborate with VA Palo Alto Health Care System and Stanford HAI to use AI on large patient datasets to guide personalized interventions and continuously monitor treatment effectiveness.

Each year for five years, the center will fund 10 to 15 research projects pursuing AI-driven interventions tailored to individual characteristics and changing needs.

This center is part of a broader set of five NIH-funded AI dementia initiatives nationwide, signaling strong federal support for AI-driven dementia care.